rs189243324

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001145809.2(MYH14):​c.1944C>A​(p.Asp648Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000632 in 1,424,290 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. D648D) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000063 ( 0 hom. )

Consequence

MYH14
NM_001145809.2 missense, splice_region

Scores

8
11
Splicing: ADA: 0.00004499
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.78

Publications

0 publications found
Variant links:
Genes affected
MYH14 (HGNC:23212): (myosin heavy chain 14) This gene encodes a member of the myosin superfamily. The protein represents a conventional non-muscle myosin; it should not be confused with the unconventional myosin-14 (MYO14). Myosins are actin-dependent motor proteins with diverse functions including regulation of cytokinesis, cell motility, and cell polarity. Mutations in this gene result in one form of autosomal dominant hearing impairment. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
MYH14 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 4A
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.25790125).
BS2
High AC in GnomAdExome4 at 9 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYH14NM_001145809.2 linkc.1944C>A p.Asp648Glu missense_variant, splice_region_variant Exon 16 of 43 ENST00000642316.2 NP_001139281.1
MYH14NM_001077186.2 linkc.1944C>A p.Asp648Glu missense_variant, splice_region_variant Exon 16 of 42 NP_001070654.1
MYH14NM_024729.4 linkc.1920C>A p.Asp640Glu missense_variant, splice_region_variant Exon 15 of 41 NP_079005.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYH14ENST00000642316.2 linkc.1944C>A p.Asp648Glu missense_variant, splice_region_variant Exon 16 of 43 NM_001145809.2 ENSP00000493594.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000632
AC:
9
AN:
1424290
Hom.:
0
Cov.:
29
AF XY:
0.00000709
AC XY:
5
AN XY:
705494
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32424
American (AMR)
AF:
0.00
AC:
0
AN:
39320
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25478
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37576
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81242
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50778
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5720
European-Non Finnish (NFE)
AF:
0.00000824
AC:
9
AN:
1092692
Other (OTH)
AF:
0.00
AC:
0
AN:
59060
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Mar 15, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.35
BayesDel_addAF
Benign
0.0077
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
0.23
DANN
Benign
0.95
DEOGEN2
Uncertain
0.61
.;.;D;.;D;.;D
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.18
N
LIST_S2
Uncertain
0.93
.;D;D;.;D;T;.
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.26
T;T;T;T;T;T;T
MetaSVM
Benign
-0.43
T
MutationAssessor
Benign
1.3
.;.;L;.;.;.;L
PhyloP100
-1.8
PrimateAI
Uncertain
0.60
T
PROVEAN
Uncertain
-3.7
.;D;D;.;.;.;.
REVEL
Uncertain
0.43
Sift
Uncertain
0.018
.;D;D;.;.;.;.
Sift4G
Benign
0.076
T;T;T;.;T;T;T
Polyphen
0.088
B;B;B;P;.;P;B
Vest4
0.56
MutPred
0.39
.;.;Gain of ubiquitination at K639 (P = 0.0817);.;.;.;Gain of ubiquitination at K639 (P = 0.0817);
MVP
0.91
MPC
1.3
ClinPred
0.51
D
GERP RS
-4.1
Varity_R
0.28
gMVP
0.43
Mutation Taster
=67/33
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000045
dbscSNV1_RF
Benign
0.20
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs189243324; hg19: chr19-50756009; API